Literature DB >> 1691967

Relationship between intestinal permeability to [51Cr]EDTA and inflammatory activity in asymptomatic patients with Crohn's disease.

L Pironi1, M Miglioli, E Ruggeri, M Levorato, M A Dallasta, C Corbelli, M G Nibali, L Barbara.   

Abstract

The relationship between intestinal permeability to an oral dose (100 mu Ci) of [51CR]EDTA and the inflammatory activity of Crohn's disease was studied in 63 adult patients (32 unresected and 31 resected) who underwent 162 evaluations. The results of the [51CR]EDTA test were compared with the serum levels of the acute-phase reactant proteins (APRP) and with the result of the [111In]leukocyte scanning, respectively, as an indirect and direct method to assess intestinal inflammation. In a group of healthy adult controls, the upper normal value for the 24-hr urinary [51CR]EDTA excretion was 3.61 (97.5% percentile) and the mean coefficient of variation was 21%. Sensitivity and specificity of the [51CR]EDTA test in identifying active inflammation expressed by increased serum levels of APRP were, respectively, 97% and 54% in the unresected group and 68% and 52% in the resected group of patients. The low specificity of the test was due to the presence of increased [51CR]EDTA urinary excretion in about half the cases with normal serum levels of APRP. The [111In]leukocyte scanning was performed in a subgroup of 11 patients (three unresected and eight resected) with normal serum levels of APRP, six with increased and five with normal [51CR]EDTA urinary excretion. All six patients with increased intestinal permeability had a positive 111In image of mild to moderate degree of activity. A positive 111In scan was present in two of the five patients with normal permeability; these were two resected patients.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1691967     DOI: 10.1007/bf01540405

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  23 in total

1.  Biological measurements of Crohn's disease activity--a reassessment.

Authors:  C André; L Descos; F André; J Vignal; P Landais; J Fermanian
Journal:  Hepatogastroenterology       Date:  1985-06

2.  Lactulose, 51Cr-labelled ethylenediaminetetra-acetate, L-rhamnose and polyethyleneglycol 400 [corrected] as probe markers for assessment in vivo of human intestinal permeability.

Authors:  D G Maxton; I Bjarnason; A P Reynolds; S D Catt; T J Peters; I S Menzies
Journal:  Clin Sci (Lond)       Date:  1986-07       Impact factor: 6.124

3.  Reversibility of increased intestinal permeability to 51Cr-EDTA in patients with gastrointestinal inflammatory diseases.

Authors:  R T Jenkins; D B Jones; R L Goodacre; S M Collins; G Coates; R H Hunt; J Bienenstock
Journal:  Am J Gastroenterol       Date:  1987-11       Impact factor: 10.864

4.  Assessment of appropriate laboratory measurements to supplement the Crohn's disease activity index.

Authors:  C Andre; L Descos; P Landais; J Fermanian
Journal:  Gut       Date:  1981-07       Impact factor: 23.059

5.  Evaluation of mannitol, lactulose and 51Cr-labelled ethylenediaminetetra-acetate as markers of intestinal permeability in man.

Authors:  M Elia; R Behrens; C Northrop; P Wraight; G Neale
Journal:  Clin Sci (Lond)       Date:  1987-08       Impact factor: 6.124

6.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.

Authors:  W R Best; J M Becktel; J W Singleton; F Kern
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

7.  Small bowel and colonic permeability to 51Cr-EDTA in patients with active inflammatory bowel disease.

Authors:  R T Jenkins; J K Ramage; D B Jones; S M Collins; R L Goodacre; R H Hunt
Journal:  Clin Invest Med       Date:  1988-04       Impact factor: 0.825

8.  Indium-111-labeled autologous leukocytes in man.

Authors:  M L Thakur; J P Lavender; R N Arnot; D J Silvester; A W Segal
Journal:  J Nucl Med       Date:  1977-10       Impact factor: 10.057

9.  A persistent defect in intestinal permeability in coeliac disease demonstrated by a 51Cr-labelled EDTA absorption test.

Authors:  I Bjarnason; T J Peters; N Veall
Journal:  Lancet       Date:  1983-02-12       Impact factor: 79.321

10.  Absorption of 51chromium-labeled ethylenediaminetetraacetate in inflammatory bowel disease.

Authors:  I Bjarnason; C O'Morain; A J Levi; T J Peters
Journal:  Gastroenterology       Date:  1983-08       Impact factor: 22.682

View more
  13 in total

Review 1.  Adaptation of intestinal nutrient transport in health and disease. Part II.

Authors:  A B Thomson; G Wild
Journal:  Dig Dis Sci       Date:  1997-03       Impact factor: 3.199

Review 2.  Intestinal permeability.

Authors:  I Bjarnason
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

Review 3.  Intestinal permeability, leaky gut, and intestinal disorders.

Authors:  D Hollander
Journal:  Curr Gastroenterol Rep       Date:  1999-10

4.  Increased pulmonary and intestinal permeability in Crohn's disease.

Authors:  A Adenis; J F Colombel; P Lecouffe; B Wallaert; B Hecquet; X Marchandise; A Cortot
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

5.  Increased absorption of polyethylene glycol 600 deposited in the colon in active ulcerative colitis.

Authors:  S Almer; L Franzén; G Olaison; K Smedh; M Ström
Journal:  Gut       Date:  1993-04       Impact factor: 23.059

Review 6.  Intestinal permeability to [51Cr]EDTA in infectious diarrhea.

Authors:  M J Zuckerman; M T Watts; B D Bhatt; H Ho
Journal:  Dig Dis Sci       Date:  1993-09       Impact factor: 3.199

7.  Test conditions greatly influence permeation of water soluble molecules through the intestinal mucosa: need for standardisation.

Authors:  M Peeters; M Hiele; Y Ghoos; V Huysmans; K Geboes; G Vantrappen; P Rutgeerts
Journal:  Gut       Date:  1994-10       Impact factor: 23.059

8.  Mechanisms of increased intestinal [51Cr]EDTA absorption during experimental colitis in the rat.

Authors:  N Pantzar; G M Ekström; Q Wang; B R Weström
Journal:  Dig Dis Sci       Date:  1994-11       Impact factor: 3.199

9.  Cellular and molecular mechanisms that mediate basal and tumour necrosis factor-alpha-induced regulation of myosin light chain kinase gene activity.

Authors:  Dongmei Ye; Thomas Y Ma
Journal:  J Cell Mol Med       Date:  2008-03-14       Impact factor: 5.310

Review 10.  Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut.

Authors:  Andrea Michielan; Renata D'Incà
Journal:  Mediators Inflamm       Date:  2015-10-25       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.